Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-16

Clinical Trial Update: The Use of ADV6209 for Premedication in Pediatric Anesthesia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating ADV6209 as a premedication in pediatric anesthesia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADV6209

Snippet

Sponsor: Medical University of Vienna | Conditions: Preanesthetic Medication | Phase 4 | Status: COMPLETED